Noetic
Venture capitalToronto, Ontario · Seed–Series A · 2 people tracked
Also known as GREY HOUSE PARTNERS GP INC. · Noetic (US) · Noetic Psychedelic
Investment thesis
Noetic invests in early-stage companies developing evidence-backed solutions for mental, emotional, and physiological health. Its diversified, multi-modal strategy covers novel drug therapeutics, psychedelic-assisted therapies, digital health, medical devices, wearables, and CNS-targeted therapeutics. The firm takes a global outlook and prioritizes treatments that address the root causes of illness while emphasizing early intervention and prevention. Noetic seeks teams with the skills, expertise, management experience, and governance structures needed to build world-class companies, and is committed to developing sustainable, innovative, safe, and accessible therapies, products, and services to improve the mental health landscape for current and future generations.
Source: firm website, verified Aug 11, 2026.
Team · 2 people
from public directories
What they invest in
from 15 of 30 portfolio companiesBiotech ×10Healthtech ×8Digital Health ×5Mental Health ×5Medical Devices ×3Wellness & Fitness ×3AI & Machine Learning ×2Deep Tech ×2
HQs:United States×4Canada×1
Investments · 30 tracked
founders shown can be your intro pathBy year:2023 · 12020 · 12 dated
HealthtechPittsburgh, US
Kathryn Fantauzzi(Executive Officer, Director, Promoter)
Board seatSa'ad Shah· per SEC Form D · $15M raise · filed Apr 2024
AtaiBeckley develops rapid-acting and durable mental health treatments for patients with difficult-to-treat mental health conditions.
BiotechMedical DevicesMental Health
Christian AngermayerSrinivas Rao
Damona Pharma develops therapies targeting cognitive deficits by using positive allosteric modulators to restore neural connections and improve brain cell communication.
BiotechHealthtechMedical Devices
Gilgamesh Pharmaceutical develops novel chemical entities for psychiatric disorders using medicinal chemistry and AI-powered translational platforms to design rapid-acting therapies targeting neurobiological mechanisms rather than symptom management.
AI & Machine LearningBiotechDigital HealthHealthtechNew York City, US
Jonathan Sporn(Founder)inAndrew Kruegel(Founder)inDalibor Sames(Founder)inJONATHAN SPORN(Founder)inThomas Kevin Murphy, Ph.D.(Executive Officer)Andrew Kruegel, Ph.D.(Executive Officer)
Merlyn builds AI-based solutions designed for education, aimed at schools and classrooms.
AI & Machine LearningEdTech
Psych Central is a mental health information website providing content and products for informational purposes.
Digital HealthMedia & EntertainmentMental Health
Audio-visual technology to accelerate physical recovery and improve mental wellbeing.
HealthtechLafayette, US
Richard Hanbury(Executive Officer, Director, Promoter)
A psychedelics research organization that discovers new psychoactive substances and develops compounds and delivery systems for therapeutic use, continuing the work of Dr.
BiotechDeep TechDigital Health
Vessel Health offers at-home urine testing and health monitoring solutions designed to help users track and improve their wellness.
Digital HealthHealthtechWellness & FitnessSan Diego, US
Jon Carder(Executive Officer, Director)Jared Stein(Director)
Wake offers medicinal and psychedelic fungi therapy combined with genomics-based integration aimed at supporting human health and personal transformation.
BiotechHealthtechWellness & Fitness
Woven Science backs, incubates, and builds companies in the psychedelic and wellness space, operating across drug development, health technology, and plant-medicine product development and distribution.
BiotechMental HealthWellness & Fitness
Nick von Christierson(CEO & Co-Founder)Giles Hayward(President & Co-Founder)Riwa Harfoush(Chief Strategy Officer)Louis Sagar(Chief Experience Officer)Helen Sartory(Chief Financial Officer)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 2
IPOs and acquisitions across the tracked portfolioCompass PathwaysNASDAQ: CMPSCybinNASDAQ: HELP
Portfolio news
latest coverage across their companiesBeckley Psytech · wmbdradio.com · Jul 16, 2026
Gilgamesh Pharmaceuticals · wmbdradio.com · Jul 16, 2026
Frequently asked questions
- What stage does Noetic invest at?
- Noetic invests at the Seed, Series A stages.
- What sectors does Noetic focus on?
- Noetic focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices, Mental Health, Wellness & Fitness.
- Where is Noetic located?
- Noetic is headquartered in Toronto, Ontario, CA.
Media · Podcasts & interviews
featuring the teamSa'ad Shah, Investing $150M to Fix The Mental Health Crisis With Noetic Capital | Brick By Brick 014
Ollie Allen Fox · Sa'ad Shah
#opnaskaninvestor - Sa'ad Shah, Managing Partner, Noetic Fund
Open People Network · Sa'ad Shah
Images
Similar investors
JAZZ Venture Partners is a venture capital firm investing in companies at the intersection of technology, neuroscience, and human performance, spanning digital health, biosciences, and AI.
PsyMed Ventures is a venture firm investing in frontier technologies advancing brain and mental health, including neurotech, digital health, precision neuroscience, and novel therapeutics.
Everywhere Ventures is an early-stage venture firm that backs founders globally, supported by a community of founders and operators as LPs.
SteelSky Ventures is an AI-focused healthcare technology venture fund that backs companies expanding access to care, with particular emphasis on women's health and underserved populations.
Pave Health Ventures is an early-stage investor and company builder focused on health, backing founders from the ideation stage across products, technology, and tech-enabled services.